Form 13-F position report

LB PHARMACEUTICALS INC

Reported by Spark Investment Management LLC

LBRX CUSIP 50180M108 Manager CIK 0001554871

First reported at 16,700 shares this quarter.

New
% of reported 13F value 1.02% This manager · Q3 2026
Shares 16,700 Quarter-end amount reported
Reported value $640,946 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-09-30 640946

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for LB PHARMACEUTICALS INC held by Spark Investment Management LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 New 16,700 +16,700 (0.0%) 1.02% $640,946 2026-11-13

Who else reported the position

157 managers reported LB PHARMACEUTICALS INC for Q3 2026.

Managers reporting LB PHARMACEUTICALS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Deep Track Capital LP Unchanged 3,352,804 0 2.1% $128,680,617 5 qtrs
BlackRock Inc Reduced 2,346,785 -387,520 < 0.01% $90,069,607 5 qtrs
RA CAPITAL MANAGEMENT L P Unchanged 2,208,604 0 0.85% $84,766,222 5 qtrs
Spruce Street Capital LP Added 1,404,779 +28,620 8.56% $53,863,456 4 qtrs
JPMorgan Chase & Co Reduced 1,444,215 -53,078 < 0.01% $53,840,336 5 qtrs
Caligan Partners LP Added 1,509,621 +71,551 3.04% $49,621,242 3 qtrs
COMMODORE CAPITAL LP Reduced 1,282,273 -217,727 3.81% $49,213,638 5 qtrs
Trails Edge Capital Partners LP Reduced 1,149,240 -373,782 6.34% $44,107,831 4 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 1,099,880 +128,715 < 0.01% $42,213,394 3 qtrs
Nantahala Capital Management LLC Added 1,074,374 +21,480 1.3% $41,234,474 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
COM SHS

Voting authority reported

Sole
16,700
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.